C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
11/2004
11/03/2004	CN1543343A Preparation and diabetic use of gibberellins
11/03/2004	CN1542002A Inhibitors of metalloproteinase, pharmaceutical compositions containing them, their pharmaceutical application and methods and intermediate compounds for their preparation
11/03/2004	CN1173981C Preparation of vitamin C-RE complex
11/03/2004	CN1173974C Piperidylaminomethyltrifluoromethyl cyclic ether compound as p substance antagonist
11/03/2004	CN1173964C Novel benzofuranone derivative and process for producing same
11/03/2004	CN1173963C Stereospecific hydrolysis of optically active esters
11/03/2004	CN1173947C 2,4,5-trisubstituted phenylketo-enols for use as pesticides and herbicides
11/03/2004	CN1173944C New vitamin-D derivatives with carbon ring or heterocyclic substitutents at C-25, process for the preparation, intermediate products and their use for producing medicaments
11/03/2004	CN1173937C (3S,4S) and (3R,4R)-beta-methyl-gamma-hydroxy-alkyl nitrile and its preparation and use
11/02/2004	US6812355 Process for the manufacture of citalopram hydrobromide from 5-bromophthalide
11/02/2004	US6812354 Mild catalytic reduction of 3-hydroxymethyltetrahydrofuran or 3-formyltetrahydrofuran with secondary alcohol hydrogen source
11/02/2004	US6812351 Hollow cylindrical catalyst and a method for producing a maleic acid anhydride
11/02/2004	US6812237 (arylaminoaceamido)acetonitrile derivatives
11/02/2004	US6812186 Using reaction product of diisopropylamine and metal hydroxide
11/02/2004	US6811998 Conjugates of uncompetitive inhibitors of inosine monophosphate dehydrogenase
11/02/2004	CA2094806C Aminosulfonyl urea acat inhibitors
10/2004
10/28/2004	WO2004092153A1 Diamine derivative, production process, and antioxidizing drug
10/28/2004	WO2004092152A1 Process for making allyl succinic anhydride
10/28/2004	WO2004092145A1 Alpha substituted carboxylic acid as ppar modulators
10/28/2004	WO2004092117A1 Para-sulfonyl substituted phenyl compounds as modulators of ppars
10/28/2004	WO2004092116A1 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof
10/28/2004	WO2004092115A2 Hydroxamates as therapeutic agents
10/28/2004	WO2004092100A1 Indene derivatives as pharmaceutical agents
10/28/2004	WO2004091604A1 Compounds that modulate ppar activity and methods of preparation
10/28/2004	WO2004083197A3 Intermediates for the preparation of citalopram and escitalopram
10/28/2004	WO2004080379A3 Extract of pangium edule and lignanes which can be used as a cathepsin inhibitor or having an antinecrotic effect
10/28/2004	WO2004071442A3 Novel bicyclic compounds and compositions
10/28/2004	WO2004064806A3 Process for modifying drug crystal formation
10/28/2004	US20040215025 formation of by-products by polymerisation of the alkylating agent is avoided whereby a reduction in the amount of alkylating reagent to be used is made possible; high yields
10/28/2004	US20040214896 drugs and/or prodrugs such as N-hydroxy-6-(4-(4-chlorophenyl)phenyl)-6-hydroxyhexanamide, used for prophylaxis of inflammatory disorders, cancers, psoriasis, diabetes, autoimmune diseases, hepatitis, graft versus host disease or endometriosis
10/28/2004	US20040214890 1,3-diamino-2-hydroxypropane derivatives are useful as inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mammal
10/28/2004	US20040214888 Carboxylic acid derivative and medicine comprising salt or ester of the same
10/28/2004	US20040214869 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia
10/28/2004	US20040214862 A N'-hydroxy-terephthalamide derivatives; histone deacetylase enzyme inhibitors; ANTIPROLIFERATIVE AGENTS; ANTITUMOR AGENTS
10/28/2004	US20040214846 A heteroaryl carbamic acid, secondary amide or amine, or phthalimidoyl derivatives; prevent from getting the disease or condition; cognitive impairment, Down's syndrome, Hereditary Cerebral Hemorrhage with Amyloidosis of the Dutch-Type, cerebral amyloid angiopathy, neurodegenerative disease
10/28/2004	US20040214827 for the treatment and/or prevention of medical dysfunctions and diseases such as stroke, Parkinson's disease, and Alzheimer's disease caused by reactive oxygen species and/or excess Zn ions; neuroprotectants
10/28/2004	US20040214822 Substituted 4-aminocyclohexanol compounds
10/28/2004	CA2522118A1 Compounds that modulate ppar activity and methods of preparation
10/28/2004	CA2521937A1 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof
10/28/2004	CA2521915A1 Alpha substituted carboxylic acid as ppar modulators
10/28/2004	CA2521883A1 Indene derivatives as pharmaceutical agents
10/28/2004	CA2521175A1 Para-sulfonyl substituted phenyl compounds as modulators of ppars
10/27/2004	EP1471056A1 Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same
10/27/2004	EP1471054A1 Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these
10/27/2004	EP1471049A1 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof
10/27/2004	EP1470752A1 Insecticides containing hydrazone derivatives as the active ingredient and novel hydrazone derivatives
10/27/2004	EP1470118A1 Alpha-methylenelactone synthesis in supercritical fluids
10/27/2004	EP1470117A1 Methylenelactone synthesis in supercritical fluids
10/27/2004	EP1470100A1 Triarylamine derivatives and the use thereof in organic electroluminescent and electrophotographic devices
10/27/2004	EP1404687A4 Fluorous triphase and other multiphase systems
10/27/2004	EP1272456B1 Hydrazide and alkoxyamide angiogenesis inhibitors
10/27/2004	EP0960108B1 Matrix metalloproteinase inhibitors
10/27/2004	CN1541211A Derivatives of N-(arylsulfonyl) beta-aminoacids comprising substituted aminomethyl group, prepn. method thereof and pharmaceutical compsns. contg same
10/27/2004	CN1539835A Method for splitting antipode of 3-butylbenzene phthalein
10/27/2004	CN1539834A Method for preparing handy amino-tetrahydrofurans or its salts
10/27/2004	CN1539832A Process for preparing oxazolines from tetrahydrofurans
10/27/2004	CN1172664C Agent for lowering prolactin
10/26/2004	US6809208 3-Arylbenzofuranones with electron-withdrawing substituents as stabilizers
10/26/2004	US6809176 Compounds for use in treatment of cancer
10/26/2004	US6809100 Hydroxamic acid derivatives
10/26/2004	US6809089 Sulfonylaminocarboxylic acid N-arylamides as guanylate cyclase activators
10/26/2004	US6808724 Artemisolide compound isolated from the aerial parts of Artemisia sylvatica, isolation method, and use thereof
10/26/2004	CA2261827C Use of amines to produce drugs for preventing tumour cell proliferation
10/21/2004	WO2004089946A1 Microwave synthesis of mycophenolate
10/21/2004	WO2004089941A1 New heterocyclic compounds, a process for their preparation and their use as dyes and pigments
10/21/2004	WO2004089940A1 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
10/21/2004	WO2004089924A1 Process for the preparation of 5-bromophthalide
10/21/2004	WO2004089885A1 Novel compounds
10/21/2004	WO2004089410A1 Preventive and/or remedy for neuropathic pain
10/21/2004	WO2003100081A3 Biologically active maleamic acid derivatives with labile amide bonds
10/21/2004	US20040210080 3-(oxo, oxime, hydrazone, or alkylidene)-fluorene derivatives; can be synergistically combined with other anticarcinogenic, anticholesterol, anxiolytic agents, antidepressants or enzyme inhibitors; bone disorders
10/21/2004	US20040210066 Process for producing benzofuran derivative
10/21/2004	US20040209946 Synthesis of 2-hydroxy-N,N-dimethyl-3-[[2-[1(R)-(5-methyl-2-furanyl)propyl]amino]-3,4-dioxo-1-cyclobuten-1-l]aminobenzamide
10/21/2004	US20040209945 Process for the production of beraprost and its salts
10/21/2004	US20040209936 Compounds that modulate PPAR activity and methods of preparation
10/21/2004	US20040209822 Novel compounds
10/21/2004	US20040209778 Lactone derivative, and plant growth regulator and rooting agent each containing the same as active ingredient
10/21/2004	CA2522023A1 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
10/21/2004	CA2521000A1 Preventive and/or therapeutic agent for neuropathic pain
10/21/2004	CA2519157A1 New heterocyclic compounds, a process for their preparation and their use as dyes and pigments
10/20/2004	EP1468990A1 Piperazine derivative
10/20/2004	EP1468979A1 Process for preparing S-(-)-chlorosuccinic acid
10/20/2004	EP1467989A1 Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatitis c virus infection
10/20/2004	EP1467982A1 Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them, and uses thereof
10/20/2004	EP1467725A1 Method for the preparation of lariciresinol, cyclolariciresinol and secoisolariciresinol
10/20/2004	EP1443045A9 Carbanilide used as pesticide
10/20/2004	EP0830136B1 New cryptophycins from synthesis
10/20/2004	CN1538956A Spiro compounds
10/20/2004	CN1538955A Pyrrolidine derivatives as factor Xa inhibitors
10/20/2004	CN1537849A Hydroxy stilbene kind compound and its preparation method and application
10/20/2004	CN1537848A Process for simultaneous production of maleic anlydride and its hydrogenated derivatives
10/20/2004	CN1171884C Neotriterpenoid and its extraction and separation process
10/20/2004	CN1171883C Nonsteroidal antiinflammatories
10/20/2004	CN1171872C Compounds for modulation of PPAP gamma activity
10/20/2004	CN1171859C Fungicide and insecticide benzyloxycyclopropyl substituted aromatic compound fungicide
10/20/2004	CN1171675C Catalyst for preparing furancarbinol from liquid-phase furol hydrogenation and use thereof
10/19/2004	US6806378 Catalyst system and a process for the preparation of a nonracemic chiral alcohol by hydrogenation of a ketone using the catalyst system, wherein the catalyst system comprises ruthenium, a nonracemic chiral diphosphine ligand, an
10/19/2004	US6806376 Method for the preparation of citalopram
10/19/2004	US6806287 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
10/19/2004	US6806264 Arylphenyl-substituted cyclic ketoenols

1 ... 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 ... 472